[A phase I study of combination chemotherapy using TS-1 and weekly paclitaxel for advanced gastric cancer]

Autor: Yoshiyuki, Fujiwara, Jyunya, Fujita, Kazuomi, Kan, Kousei, Tsukahara, Shuji, Takiguchi, Hiroshi, Miyata, Takushi, Yasuda, Yuichirou, Doki, Morito, Monden
Rok vydání: 2006
Předmět:
Zdroj: Gan to kagaku ryoho. Cancerchemotherapy. 33(1)
ISSN: 0385-0684
Popis: The safety of chemotherapy combining TS-1 and weekly paclitaxel for the treatment of unresectable and recurrent gastric cancer was evaluated in this study. Paclitaxel was administered by intravenous drip infusion at a starting dose (level 1) of 50 mg/m2 on days 1, 8, and 15. TS-1 was administered orally at a dose of 40 mg/m2twice a day for 2 weeks (days 1-14) followed by 2 weeks rest. A total of 9 patients were enrolled in this study. Two out of 6 patients treated with level 1 suffered from leukocytopenia and neutropenia, which were determined as dose-limiting toxicity (DLT). Three patients were treated with level 2, in which the dose of paclitaxel was increased up to 60 mg/m2. One of 3 patients suffered from grade 3 diarrhea and one patient from grade 4 leukocytopenia, eutrocytopenia, anemia, and stomatitis, which were determined as DLT. According to these results,level 1 of this regimen was recommended as a safe treatment for gastric cancer patients. A phase II study will be performed to evaluate the efficacy of the combination chemotherapy.
Databáze: OpenAIRE